XML 52 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED CASH FLOW STATEMENTS (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 28, 2014
Sep. 29, 2013
Cash flows from operating activities:    
Net income $ 58,456 $ 80,805
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 74,382 71,863
Share-based compensation 14,236 11,126
Provision for inventory obsolescence 4,885 2,541
Pension funding less than pension expense 1,786 2,876
Income from equity method investment (3,240) (5,285)
Deferred income tax benefit (4,693) (1,984)
Tax benefit related to share-based compensation (4,939) (10,581)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:    
Receivables (44,583) (40,214)
Inventories (697) 1,172
Accounts payable (7,613) 7,812
Accrued liabilities (24,414) 9,875
Accrued taxes (9,125) (84,189)
Other assets 8,856 2,565
Other liabilities 1,469 2,421
Net cash provided by operating activities 64,766 50,803
Cash flows from investing activities:    
Cash used to acquire businesses, net of cash acquired (313,065) (9,979)
Capital expenditures (31,057) (31,405)
Proceeds from (payments for) disposal of business (956) 3,735
Proceeds from disposal of tangible assets 1,773 3,155
Net cash used for investing activities (343,305) (34,494)
Cash flows from financing activities:    
Borrowings under credit arrangements 200,000 388,220
Payments under share repurchase program (62,197) (93,750)
Proceeds (payments) from exercise of stock options, net of withholding tax payments (7,996) (2,274)
Debt issuance costs paid (6,572) (7,817)
Cash dividends paid (6,540) (4,488)
Payments under borrowing arrangements (1,250) (200,220)
Tax benefit related to share-based compensation 4,939 10,581
Net cash provided by financing activities 120,384 90,252
Effect of foreign currency exchange rate changes on cash and cash equivalents (6,047) 2,181
Increase (decrease) in cash and cash equivalents (164,202) 108,742
Cash and cash equivalents, beginning of period 613,304 395,095
Cash and cash equivalents, end of period $ 449,102 $ 503,837